What Vaxart Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 5 |
| Sells | 0 | 0 |
| Total trades | 1 | 33 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 78,800 | 2,160,366 |
| Disposed | 0 | 394,015 |
| Net activity | +78,800 | +1,766,351 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bono Raquel C. | Director | Oct 16 | Grant / award · A | +78,800 | — | — | 78,800 |
| Heron Elaine J | Director | Jul 16 | Grant / award · A | +39,400 | — | — | 135,966 |
| Wheadon David E. | Director | Jul 16 | Grant / award · A | +39,400 | — | — | 86,150 |
| Watson W. Mark | Director | Jul 16 | Grant / award · A | +39,400 | — | — | 173,525 |
| Breitmeyer James B | Director | Jul 16 | Grant / award · A | +8,315 | — | — | 87,115 |
| Finney Kevin | Director | Jul 16 | Grant / award · A | +39,400 | — | — | 244,171 |
| Watson W. Mark | Director | May 22 | Open-market buy · P | +10,000 | $0.65 | +$6.53K | 134,125 |
| Grasman Jeroen Nicolaas | Chief Financial Officer | May 19 | Withheld — tax / exercise cost · F | −31,395 | $0.61 | −$19.2K | 545,605 |
| Breitmeyer James B | Director | Apr 23 | Grant / award · A | +78,800 | — | — | 78,800 |
| Cummings James F. | Chief Medical Officer | Mar 28 | Withheld — tax / exercise cost · F | −3,292 | $0.65 | −$2.14K | 924,177 |
| Tucker Sean | SVP, Chief Scientific Officer | Mar 28 | Withheld — tax / exercise cost · F | −3,924 | $0.65 | −$2.55K | 882,811 |
| Tucker Sean | SVP, Chief Scientific Officer | Mar 24 | Withheld — tax / exercise cost · F | −36,418 | $0.69 | −$25.3K | 886,735 |
| Lo Steven | President, Chief Exec Officer | Mar 24 | Withheld — tax / exercise cost · F | −126,028 | $0.69 | −$87.5K | 2,485,606 |
| Cummings James F. | Chief Medical Officer | Mar 24 | Withheld — tax / exercise cost · F | −30,551 | $0.69 | −$21.2K | 927,469 |
| Berg Edward B | SVP, General Counsel | Mar 24 | Withheld — tax / exercise cost · F | −36,418 | $0.69 | −$25.3K | 755,368 |
| Tucker Sean | SVP, Chief Scientific Officer | Mar 18 | Withheld — tax / exercise cost · F | −8,072 | $0.63 | −$5.12K | 923,153 |
| Lo Steven | President, Chief Exec Officer | Mar 18 | Withheld — tax / exercise cost · F | −22,425 | $0.63 | −$14.2K | 2,611,634 |
| Cummings James F. | Chief Medical Officer | Mar 18 | Withheld — tax / exercise cost · F | −6,772 | $0.63 | −$4.3K | 958,020 |
| Berg Edward B | SVP, General Counsel | Mar 18 | Withheld — tax / exercise cost · F | −8,072 | $0.63 | −$5.12K | 791,786 |
| Berg Edward B | SVP, General Counsel | Mar 16 | Grant / award · A | +115,000 | — | — | 799,858 |
Loading...
